Nodal-stage classification in invasive lobular breast carcinoma: influence of different interpretations of the pTNM classification.

PURPOSE Application of current nodal status classification is complicated in lobular breast carcinoma metastases. The aim of this study was to define the optimal interpretation of the pTNM classification in sentinel node (SN) -positive patients to select patients with limited or with a high risk of non-SN involvement. PATIENTS AND METHODS SN metastases of 392 patients with lobular breast carcinoma were reclassified according to interpretations of the European Working Group for Breast Screening Pathology (EWGBSP) and guidelines by Turner et al, and the predictive power for non-SN involvement was assessed. Results Reclassification according to definitions of EWGBSP and Turner et al resulted in different pN classification in 73 patients (19%). The rate of non-SN involvement in the 40 patients with isolated tumor cells according to Turner et al and with micrometastases according to EWGBSP was 20%, which is comparable to the established rate for micrometastases. The rate of non-SN involvement in the 29 patients with micrometastases according to Turner et al and with macrometastases according to EWGBSP was 48%, which is comparable to the established rate for macrometastases. Therefore, the EWGBSP method to classify SN tumor load better reflected the risk of non-SN involvement than the Turner et al system. CONCLUSION Compared with the guidelines by Turner et al, the EWGBSP definitions better reflect SN metastatic tumor load and allow better differentiation between patients with lobular breast carcinoma who have a limited or a high risk of non-SN metastases. Therefore, we suggest using the EWGBSP definitions in these patients to select high-risk patients who may benefit from additional local and/or systemic therapy.

[1]  P. V. van Diest,et al.  Micrometastases or isolated tumor cells and the outcome of breast cancer. , 2009, The New England journal of medicine.

[2]  P. V. van Diest,et al.  Non-sentinel lymph node metastases associated with isolated breast cancer cells in the sentinel node. , 2008, Journal of the National Cancer Institute.

[3]  A. Luini,et al.  Clinicopathologic characteristics of invasive lobular carcinoma of the breast , 2008, Cancer.

[4]  P. V. van Diest,et al.  Variations in sentinel node isolated tumour cells/micrometastasis and non-sentinel node involvement rates according to different interpretations of the TNM definitions. , 2008, European journal of cancer.

[5]  V. Brouste,et al.  Distinction between isolated tumor cells and micrometastases in breast cancer , 2008, Cancer.

[6]  D. Boulware,et al.  Significance of sentinel lymph node micrometastases in human breast cancer. , 2008, Journal of the American College of Surgeons.

[7]  A. Giuliano,et al.  Nodal stage classification for breast carcinoma: improving interobserver reproducibility through standardized histologic criteria and image-based training. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  P. V. van Diest,et al.  Predictive Value of Tumor Load in Breast Cancer Sentinel Lymph Nodes for Second Echelon Lymph Node Metastases , 2007, Cellular oncology : the official journal of the International Society for Cellular Oncology.

[9]  P. V. van Diest,et al.  Introduction of sentinel node biopsy and stage migration of breast cancer. , 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[10]  A. Sapino,et al.  Discriminating between micrometastases and isolated tumor cells in a regional and institutional setting. , 2006, Breast.

[11]  O. Fadare Improving the reproducibility of diagnosing micrometastases and isolated tumor cells , 2005, Cancer.

[12]  G. Pruneri,et al.  Predicting the Risk for Additional Axillary Metastases in Patients With Breast Carcinoma and Positive Sentinel Lymph Node Biopsy , 2005, Annals of surgery.

[13]  S. Bianchi,et al.  Improving the reproducibility of diagnosing micrometastases and isolated tumor cells , 2005, Cancer.

[14]  L. Sobin,et al.  Classification of isolated tumor cells , 2003, Cancer.

[15]  K. Griffith,et al.  Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma patients , 2003, Cancer.

[16]  G. Lindberg,et al.  Interpretive disparity among pathologists in breast sentinel lymph node evaluation. , 2003, American journal of surgery.

[17]  J. Peterse,et al.  Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines. , 2003, European journal of cancer.

[18]  K. Rothman Epidemiology: An Introduction , 2002 .

[19]  P. V. van Diest,et al.  Histopathological workup of sentinel lymph nodes: how much is enough? , 1999, Journal of clinical pathology.

[20]  K. Allison,et al.  Impact and Outcomes of Routine Microstaging of Sentinel Lymph Nodes in Breast Cancer: Significance of the pN0(i+) and pN1mi Categories , 2008, Annals of Surgical Oncology.

[21]  P. Bult,et al.  Risk Factors for Non-Sentinel Lymph Node Metastases in Patients with Breast Cancer. The Outcome of a Multi-institutional Study , 2006, Annals of Surgical Oncology.